Zimmer Holdings Inc. (NYSE:ZMH) brought in a new president to lead its global business unit. Former Stryker Corp. (NYSE:SYK) executive Jeffrey Paulsen will lead the Warsaw, Ind.-based orthopedics giant’s international operations.
[Read more of this report]Thirty-two year hospital veteran Kevin Miller is scheduled to begin a three-year term with the Ohio Hospital Association’s board of trustees in January.
[Read more of this report]The consumer health services provider has appointed former Indianapolis mayor Stephen Goldsmith to sit on its board of directors.
[Read more of this report]M. Steven Jones begins Monday as president in Geauga County, on the eastern border of Cleveland’s Cuyahoga County. He served as the vice president there and earlier was vice president of the health systems’ musculoskeletal and neuroscience services at UH.
[Read more of this report]Brett S. Himes takes over for former chief executive Jerry C. Cirino, who left sister company Reichert. Reichert, which makes devices for the eye-care industry, is owned by Beecken Petty O’Keefe & Company, which also own Heartland. Cirino remains on the Heartland’s board.
[Read more of this report]Michael Fisher will take over for longtime leader Jim Anderson who is leaving at year’s end. Fisher spent five years on the hospital board and also for a time lead the Cincinnati USA Regional Chamber of Commerce.
[Read more of this report]The primary purpose of the vice president for the Battelle/Ohio State collaboration is helping with “idea generation, development and implementation” and to create a “more robust” set of joint research and economic development ventures.
[Read more of this report]CWRU medical school Dean Dr. Pamela B. Davis and CSU bioethics law professor Dena S. Davis are members of a nine-member Working Group for Human Embryonic Stem Cell Eligibility Review.
[Read more of this report]Dr. A. Marc Gillinov, who leads the Cleveland Clinic’s Center for Atrial Fibrillation, has joined the scientific advisory board of the New Jersey device company Endovalve.
[Read more of this report]Akebia called Dzao a pioneer in gene therapy for vascular disease. His research on the renin-angiotensin system (RAS), which regulates blood pressure, is credited with helping understand the role of the system in cardiovascular disease and develop RAS-based drugs.
[Read more of this report]

